Intention to make offer

RNS Number:6843R
HydroDec Group plc
04 April 2008


                                                                    4 April 2008

                         HYDRODEC GROUP PLC ("Hydrodec")

   Intention to make all share offer for Virotec International plc ("Virotec")

Hydrodec announces that on 3 April 2008 it bought 7.75 million Virotec ordinary
shares at an average price of 7.85 pence per share. This purchase represented,
in aggregate, approximately 2.93 per cent. of the issued share capital of
Virotec.

Additionally, on 4 April 2008, Hydrodec purchased 400,000 shares at 10.0 pence
per share, increasing its total interest to 8.15 million Virotec ordinary
shares, representing approximately 3.06 per cent. of the issued share capital of
Virotec.

The Board of Hydrodec notes the announcement earlier today by the Board of
Virotec and confirms that on 3 April 2008 it approached the Board of Virotec to
inform it of yesterday's purchase of shares in Virotec referred to above and
indicated its intention to make an all share offer for Virotec on the basis of
one Hydrodec ordinary share for every 3.75 Virotec ordinary shares.  On the
basis of the share price of Hydrodec at the close of business yesterday, this
indicative offer would value each Virotec ordinary share at approximately 12p
per share.

Hydrodec also confirms that it has received indications of support for its
indicative offer from shareholders in Virotec representing in aggregate
approximately 29.25 per cent. of the issued share capital of Virotec.
Accordingly, Hydrodec either owns as a result of its purchases of Virotec
ordinary shares, or has indications of support from Virotec shareholders in
respect of, in aggregate approximately 32.31 per cent. of the issued share
capital of Virotec.

Virotec holds 54.5 million shares of Hydrodec (approximately 28.1 per cent. of
the ordinary share capital).  The Board of Hydrodec considers that Virotec
shareholders will benefit from the ownership of a direct interest in Hydrodec
rather than the indirect interest they currently own.  The combined group would
further benefit from the cancellation of the Virotec royalty and any payments
that may be due under the agreement.

If the offer becomes unconditional, Hydrodec would seek to cancel the 54.5
million Hydrodec shares owned by Virotec. This would have the effect of reducing
the issuance of new Hydrodec shares to less than 5 per cent. of the fully
diluted share capital of Hydrodec assuming full take up of the offer.

The Board of Hydrodec has now approached the Board of Virotec with a view to
obtaining a recommendation. A further announcement will be made as soon as
possible.


For further information please contact:

John Gunn, Chairman
Hydrodec Group plc
020 7621 5770

Charles Sebag-Montefiore
Robert Petch
Ludgate Investments Ltd
020 7621 5770

Nick Westlake
Anthony Richardson
Numis Securities Limited
020 7260 1000

Emma Davis
Curve PR
07764 197 003


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
OFDUSUVRWORSRAR